Translating Nobel Prize Science into the Clinic
- Date: Monday June 16th
- Time: 4:15 PM - 5:15 PM ET
- Location: Location: Boston Convention & Exhibition Center Room 258A
In 1901, the first Nobel Prize was awarded to recognize those who “have conferred the greatest benefit to humankind.” Often the work that goes into winning this prestigious award occurs over decades and uncovers the fundamental and “basic” nature of the universe. But after a scientific advancement has been recognized by the Nobel committee, will it ever deliver on its promise to confer a true benefit to humanity? During this panel, hear from scientists and company executives across different stages of drug development on how they are moving beyond just a laboratory experiment to bring “Nobel Prize-winning science” into human applications to shape the future of treatment for some of the most pressing health challenges today.
Meet the panelists & Moderator

Barbara Cheifet, PhD
Chief Editor, Nature Biotechnology

Eamonn Hobbs
President and Chief Executive Officer, Syncromune

John Lepore, MD
Chief Executive Officer, ProFound Therapeutics

Sharon Rosenzweig-Lipson, PhD
Chief Scientific Officer, Life Biosciences

Michael E.. Severino, MD
Chief Executive Officer, Tessera Therapeutics
BIO International 2025
Bringing together industry experts to discuss the next wave of innovation in biotech.
See more with LifeSci Communications
We are committed to helping our partners transform complex science into moving stories that demand—and get—attention.